On July 23, 2020, Watterson, Scott Hunter; O’Malley, Daniel; Gavai, Ashvinikumar V.; Gong, Hua; Tarby, Christine M. published a patent.Electric Literature of 1196157-51-3 The title of the patent was Heterocyclic NLRP3 modulators, for use in the treatment of cancer. And the patent contained the following:
The present invention provides compounds of Formula (I), wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human). The experimental process involved the reaction of 2-Amino-6-bromonicotinic acid(cas: 1196157-51-3).Electric Literature of 1196157-51-3
The Article related to heterocyclic nlrp3 modulator cancer, Pharmaceuticals: Formulation and Compounding and other aspects.Electric Literature of 1196157-51-3
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary